文献速递神经肿瘤

一项全国性胶质瘤WHO II-IV级患者队列中的抗癫痫与精神科药物使用情况

Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II-IV.
PubMed 文献 · J Neurooncol · 2018-11-23

研究纳入挪威癌症登记处2004-2010年诊断的1828例胶质瘤WHO II-IV级患者,关联处方数据库数据,用Cox回归分析药物治疗的焦虑和抑郁风险因素,并计算精神科药物标准化发病比。结果显示II-III级胶质瘤中使用左乙拉西坦者药物治疗的焦虑风险增加(HR 2.8,95%CI 1.7-4.9),IV级女性较男性焦虑风险增加(HR 1.5,95%CI 1.2-2.0),II-III级合并癫痫者抗抑郁药处方少于一般人群。

要点

  • II-III级胶质瘤中使用左乙拉西坦者药物治疗的焦虑风险增加,HR 2.8(95%CI 1.7-4.9)。
  • IV级胶质瘤女性较男性药物治疗的焦虑风险增加,HR 1.5(95%CI 1.2-2.0)。
  • II-III级胶质瘤合并癫痫者抗抑郁药处方少于一般人群。

核心结论

  • II-III级胶质瘤使用左乙拉西坦者药物治疗的焦虑风险增加。
  • II-III级胶质瘤合并癫痫亚组抗抑郁药使用少于一般人群。

研究设计与样本

  • 挪威癌症登记处2004-2010年诊断的胶质瘤WHO II-IV级患者数据与挪威处方数据库关联。
  • 队列共1828例,其中男性1056例、女性772例;II-III级565例,IV级1263例。
  • 采用Cox回归分析药物治疗的焦虑和抑郁风险因素,并计算精神科药物标准化发病比与一般人群比较。

主要发现

  • II-III级胶质瘤中使用左乙拉西坦者较未使用者药物治疗的焦虑风险增加,HR 2.8(95%CI 1.7-4.9)。
  • IV级胶质瘤中女性较男性药物治疗的焦虑风险增加,HR 1.5(95%CI 1.2-2.0)。
  • II-III级胶质瘤合并癫痫者抗抑郁药处方频率低于一般人群。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Glioma is the most common intracranial primary brain tumor. Patients with glioma often suffer from epilepsy, anxiety and depression. Aims of this study were to identify risk factors for drug-treated anxiety and depression, and to determine the use of psychiatric medication in a national glioma cohort. METHODS: Data from the Cancer Registry of Norway on all persons diagnosed with glioma WHO grade II-IV 2004-2010 were linked with data from the Norwegian Prescription Database. Cox regression analysis was used to assess risk factors for drug-treated anxiety and depression. Standardized incidence ratios were calculated for psychiatric medication dispensed to glioma patients and compared to the general population. RESULTS: The glioma cohort consisted of 1056 males and 772 females. Of the 1828 patients, 565 had glioma grade II-III, and 1263 had grade IV. The patients with glioma grade II-III who were treated with levetiracetam had an increased risk for drug-treated anxiety compared to patients without levetiracetam; hazard ratio 2.8 (95% confidence interval 1.7-4.9). Female gender increased the risk for drug-treated anxiety compared to males in patients with glioma grade IV; hazard ratio 1.5 (95% confidence interval 1.2-2.0). Antidepressants were less frequently dispensed to patients with glioma grade II-III and epilepsy than to the general population. CONCLUSIONS: Patients with glioma grade II-III on levetiracetam had an increased risk for drug-treated anxiety. The subgroup of patients with glioma grade II-III and epilepsy received less antidepressants than the general population.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Knudsen-Baas KM, Johannesen TB, Myklebust TÅ, et al. Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II-IV. J Neurooncol. 2018. PMID: 30471051. doi:10.1007/s11060-018-03007-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。